Literature DB >> 29573323

The interaction of the Chrna5 D398N variant with developmental nicotine exposure.

H C O'Neill1, C R Wageman1, S E Sherman1, S R Grady1, M J Marks1,2, J A Stitzel1,3.   

Abstract

A single nucleotide polymorphism (SNP) in CHRNA5 (rs16969968, change from an aspartic acid [D] to asparagine [N] at position 398 of the human α5 nicotinic acetylcholine receptor subunit) has been associated with increased risk for nicotine dependence. Consequently, carriers of the risk variant may be at elevated risk for in utero nicotine exposure. To assess whether this gene-environment interaction might impact nicotine intake in developmental nicotine-exposed offspring, we utilized a mouse expressing this human SNP. D and N dams drank nicotine (100 μg/mL) in 0.2% saccharin water or 0.2% saccharin water alone (vehicle) as their sole source of fluid from 30 days prior to breeding until weaning of offspring. The nicotine (D Nic, N Nic) or vehicle (D Veh, N Veh) exposed offspring underwent a 2-bottle choice test between postnatal ages of 30 to 46 days. N Nic offspring consumed the most nicotine at the highest concentration (400 μg/mL) compared with all other groups. In contrast, D Nic offspring drank the least amount of nicotine at all concentrations tested. Nicotine-stimulated dopamine (DA) release measured from striatal synaptosomes was increased in D Nic offspring, while decreased in N Nic offspring relative to their genotype-matched controls. These data suggest that the α5 variant influences the effect of developmental nicotine exposure on nicotine intake of exposed offspring. This gene-environment interaction on striatal DA release may provide motivation for increased nicotine seeking in N Nic offspring and reduced consumption in D Nic offspring.
© 2018 John Wiley & Sons Ltd and International Behavioural and Neural Genetics Society.

Entities:  

Keywords:  CHRNA5; D398N mouse; adolescent nicotine; development; dopamine; gene by environment interaction; nicotine; nicotine dependence; nicotinic receptors; rs16969968

Mesh:

Substances:

Year:  2018        PMID: 29573323      PMCID: PMC7313682          DOI: 10.1111/gbb.12474

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  55 in total

1.  Prenatal cigarette smoke exposure and early initiation of multiple substance use.

Authors:  Lidush Goldschmidt; Marie D Cornelius; Nancy L Day
Journal:  Nicotine Tob Res       Date:  2011-12-16       Impact factor: 4.244

Review 2.  Nicotinic, glutamatergic and dopaminergic synaptic transmission and plasticity in the mesocorticolimbic system: focus on nicotine effects.

Authors:  Francesco Pistillo; Francesco Clementi; Michele Zoli; Cecilia Gotti
Journal:  Prog Neurobiol       Date:  2014-11-03       Impact factor: 11.685

3.  Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit.

Authors:  M J Marks; P Whiteaker; J Calcaterra; J A Stitzel; A E Bullock; S R Grady; M R Picciotto; J P Changeux; A C Collins
Journal:  J Pharmacol Exp Ther       Date:  1999-05       Impact factor: 4.030

4.  Chrna5 genotype determines the long-lasting effects of developmental in vivo nicotine exposure on prefrontal attention circuitry.

Authors:  Craig D C Bailey; Michael K Tian; Lily Kang; Ryan O'Reilly; Evelyn K Lambe
Journal:  Neuropharmacology       Date:  2013-09-18       Impact factor: 5.250

5.  Nicotine reverses hypofrontality in animal models of addiction and schizophrenia.

Authors:  Fani Koukouli; Marie Rooy; Dimitrios Tziotis; Kurt A Sailor; Heidi C O'Neill; Josien Levenga; Mirko Witte; Michael Nilges; Jean-Pierre Changeux; Charles A Hoeffer; Jerry A Stitzel; Boris S Gutkin; David A DiGregorio; Uwe Maskos
Journal:  Nat Med       Date:  2017-01-23       Impact factor: 53.440

6.  Identification of a novel nicotinic binding site in mouse brain using [(125)I]-epibatidine.

Authors:  P Whiteaker; M Jimenez; J M McIntosh; A C Collins; M J Marks
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

7.  Nicotine consumption is regulated by a human polymorphism in dopamine neurons.

Authors:  C Morel; L Fattore; S Pons; Y A Hay; F Marti; B Lambolez; M De Biasi; M Lathrop; W Fratta; U Maskos; P Faure
Journal:  Mol Psychiatry       Date:  2013-12-03       Impact factor: 15.992

8.  Nicotine amplifies reward-related dopamine signals in striatum.

Authors:  Margaret E Rice; Stephanie J Cragg
Journal:  Nat Neurosci       Date:  2004-05-16       Impact factor: 24.884

9.  Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine.

Authors:  Michael J Marks; Natalie M Meinerz; John Drago; Allan C Collins
Journal:  Neuropharmacology       Date:  2007-06-07       Impact factor: 5.250

10.  A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction.

Authors:  Robert B Weiss; Timothy B Baker; Dale S Cannon; Andrew von Niederhausern; Diane M Dunn; Nori Matsunami; Nanda A Singh; Lisa Baird; Hilary Coon; William M McMahon; Megan E Piper; Michael C Fiore; Mary Beth Scholand; John E Connett; Richard E Kanner; Lorise C Gahring; Scott W Rogers; John R Hoidal; Mark F Leppert
Journal:  PLoS Genet       Date:  2008-07-11       Impact factor: 5.917

View more
  6 in total

1.  The Role of A Priori-Identified Addiction and Smoking Gene Sets in Smoking Behaviors.

Authors:  Luke M Evans; Emma C Johnson; Whitney E Melroy-Greif; John K Hewitt; Charles A Hoeffer; Matthew C Keller; Laura M Saba; Jerry A Stitzel; Marissa A Ehringer
Journal:  Nicotine Tob Res       Date:  2020-07-16       Impact factor: 4.244

2.  Mutation of the α5 nicotinic acetylcholine receptor subunit increases ethanol and nicotine consumption in adolescence and impacts adult drug consumption.

Authors:  Natalia A Quijano Cardé; Jessica Shaw; Christina Carter; Seung Kim; Jerry A Stitzel; Shyamala K Venkatesh; Vijay A Ramchandani; Mariella De Biasi
Journal:  Neuropharmacology       Date:  2022-06-22       Impact factor: 5.273

Review 3.  Linking the CHRNA5 SNP to drug abuse liability: From circuitry to cellular mechanisms.

Authors:  Julia K Brynildsen; Julie A Blendy
Journal:  Neuropharmacology       Date:  2021-02-01       Impact factor: 5.250

Review 4.  The α5 Nicotinic Acetylcholine Receptor Subunit Differentially Modulates α4β2* and α3β4* Receptors.

Authors:  Petra Scholze; Sigismund Huck
Journal:  Front Synaptic Neurosci       Date:  2020-12-03

5.  The Intergenerational Transmission of Developmental Nicotine Exposure-Induced Neurodevelopmental Disorder-Like Phenotypes is Modulated by the Chrna5 D397N Polymorphism in Adolescent Mice.

Authors:  Jordan M Buck; Heidi C O'Neill; Jerry A Stitzel
Journal:  Behav Genet       Date:  2021-06-23       Impact factor: 2.805

6.  Association between environmental tobacco smoke exposure across the first four years of life and manifestation of externalizing behavior problems in school-aged children.

Authors:  Lisa Gatzke-Kopp; Michael T Willoughby; Siri Warkentien; Daniel Petrie; Roger Mills-Koonce; Clancy Blair
Journal:  J Child Psychol Psychiatry       Date:  2019-12-03       Impact factor: 8.265

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.